Alliance with Swiss paperless lab solutions' company
Thermo Fisher Scientific has extended its reach across Central Europe by making Vialis AG the latest member of its Informatics Global Partner Alliance.
Thermo Fisher Scientific has extended its reach across Central Europe by making Vialis AG the latest member of its Informatics Global Partner Alliance. Vialis, based in Switzerland, will provide local services and support for the company’s full range of informatics solutions, including laboratory information management systems, chromatography data systems, electronic laboratory notebooks and spectroscopy software, as well as comprehensive laboratory automation and integration solutions. “Our partnership with Vialis will allow us to offer local support and service to an important scientific centre in Europe and help us build on our commitment to provide leadership and innovation to the industry,” said Dave Champagne, vice president and general manager for Thermo Fisher’s informatics business.
"Our customers will benefit from this new partnership with the global service and sales teams at Thermo Fisher Scientific,” said Dr. Ulf Fuchslueger, CEO, Vialis AG. “By offering best-in-class Thermo Scientific Informatics software, we are able to provide our customers with a comprehensive solution for managing their data and helping ensure that their laboratory workflow meets the demanding business and regulatory requirements in life sciences and other industries.”
For more information visit www.thermoscientific.com/informatics
Evaluating Antimicrobial Potential of Articaine Derivatives in Oral Infections with CMC
May 20th 2025Cell membrane chromatography (CMC) technology was used by researchers in screening efficacy and antibacterial ability of articaine (AT) derivatives in the pre-emptive treatment of oral infections.
Hydrophilic Interaction Chromatography (HILIC) and Direct Online Disruption of Lipid Nanoparticles
May 19th 2025Two proof-of-concept hydrophilic interaction chromatography HILIC) methods were developed in a joint study conducted by the University of Geneva (Switzerland), Sanofi, and the Waters Corporation—one for disrupting LNPs and retaining the mRNA, and another for detecting only unencapsulated mRNA to assess encapsulation efficiency. LCGC International spoke to Jonathan Maurer, first author of the paper that resulted from this study, about the methods and the efforts that led up to their development.
This article discusses how integrating seven prioritization strategies can enhance compound identification, support environmental risk assessment, and accelerate decision-making.
